RA Capital Management »

Zai Lab shares owned by RA Capital Management

Quarter-by-quarter ownership of Zai Lab (ZLAB) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Zai Lab

Tip: Access up to 7 years of quarterly data

All positions including Zai Lab held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zai Lab by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $107M 5.7M 18.81
2025-03-31 $47M 1.3M 36.14
2024-12-31 $34M 1.3M 26.19

More positions owned by RA Capital Management

Ascendis Pharma A/s - Sponsored Adr (ASND)
Vaxcyte Common Stock (PCVX)
Rhythm Pharmaceuticals Common Stock (RYTM)
Tyra Biosciences Common Stock (TYRA)
Sionna Therapeutics Common Stock (SION)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Nuvalent Inc-a Common Stock (NUVL)
Dianthus Therapeutics Common Stock (DNTH)
Mineralys Therapeutics Common Stock (MLYS)
Spyglass Pharma Common Stock
Wave Life Sciences Common Stock (WVE)
Septerna Common Stock (SEPN)
Disc Medicine Common Stock (IRON)
Janux Therapeutics Common Stock (JANX)

View all positions for RA Capital Management

Top funds holding Zai Lab

Rtw Investments
RA Capital Management
Frazier Life Sciences Management
Citadel Advisors
Bamco
FMR
ADAR1 Capital Management
BlackRock
Rock Springs Capital Management
Wellington Management Company
CAM Group Holding A/S
UBS Group
Jane Street
Nan Fung Trinity
Two Sigma Investments

View all funds holding Zai Lab